Parkinson’s disease is not a lifelong disease. Although modern medicine cannot cure Parkinson’s disease, I found that traditional Chinese medicine can cure Parkinson’s disease. However, because of the misunderstanding of the treatment ideas of most of Chinese doctors, they failed to achieve the goal of curing Parkinson’s disease. There are differences not only in understanding and treating Parkinson’s disease between traditional Chinese medicine and modern medicine, but also in understanding within the Chinese medicine community. Because they have not been able to cure Parkinson’s disease, they draw the conclusions from modern medicine and also believe that Parkinson’s disease is an incurable lifelong disease. This paper deeply explores the problems existing in modern medicine and traditional Chinese medicine, puts forward new ideas for understanding and treating Parkinson’s disease, and explores the correct way to understand and cure Parkinson’s disease for the medical community to overcome Parkinson’s disease.
References
[1]
Jia, J.P. and Chen, S.D. (Editor in Chief), Cui, L.Y., Wang, W., Xie, P., Luo, B.J. and Chu, L. (Deputy Editor in Chief) (2020) Neurology. 8th Edition, People’s Health Publishing House, Beijing, 337.
[2]
Chen, H.B. (2020) Chinese Parkinson’s Disease Treatment Guidelines (Fourth Edition). Chinese Journal of Neurology, 53, 973-986.
[3]
Zhao, Y.Y. and Zhang, Y.S. (2019) Recent Status of Traditional Chinese Medicine Treatment of Parkinson’s Disease. World’s Latest Medical Information Abstract, 19, 65-66.
[4]
Wang, W.F. (2019) A Report of 10 Cases of Parkinson’s Disease Cured by Xifengzhizhan Pills and Xifengzhizhan Capsules. Advances in Parkinson’s Disease, 8, 9-17.
[5]
Jia, J.P. and Chen, S.D. (Editor in Chief), Cui, L.Y., Wang, W., Xie, P., Luo, B.J. and Chu, L. (Deputy Editor in Chief) (2020) Neurology. 8th Edition, People’s Health Publishing House, Beijing, 329.
[6]
Cao, F., Sun, S.G., Tong, S.T. and Luo, F. (2003) Experimental Study on the Role of Oxygen Free Radicals in the Pathogenesis of Parkinson’s Disease. Stroke and Neuropathy, No. 5, 287-290.
[7]
Liu, J., Xiao, S.H., Zhou, D.Y., Liu, Z.L., Tao, E.X. and Xing, Y.G. (2003) Experimental Study on Early Apoptosis of Dopaminergic Neurons in Substantia Nigra Induced by 6-Hydroxydopamine in Rats. Chinese Journal of Gerontology, No. 11, 40-42.
[8]
Sun, Y.H. (2016) Effect of Medopa on the Concentration of Thromboxane B2, Endothelin and Dopamine Receptor in Patients with Parkinson’s Disease. Chinese Journal of Practical Neuropathy, 19, 19-21.
